Uncategorised - European Medical Journal

Neonatal Gut Microbiota Predict Food Allergy Risk

Neonatal gut microbiota composition is significantly associated with the risk of developing food sensitisation and food allergy

Breakthroughs in IgG4-Related Autoimmune Neuropathies

A recently published review article has shed light on significant breakthroughs in the understanding and treatment of IgG4-mediated autoimmune diseases, particularly in the realm of autoimmune neuropathies.

The Referrer’s Compass: Navigating Chronic Pain Patient Selection for SCS

This educational webinar explores the various clinical and psychosocial factors involved in selecting patients for spinal cord stimulation…

Functional Outcomes After Respiratory Failure Explored

Respiratory failure impacts millions annually in the U.S., leaving many survivors with lasting physical, cognitive, and quality-of-life impairments.

Omega-3 Diet Reduces Prostate Cancer Progression

A recent Phase II clinical trial has revealed promising results for men with low-grade prostate cancer on active surveillance (AS).

MRI May Allow Safe Avoidance of Prostate Biopsy in Some Men

A new cohort study suggests that many men with suspected prostate cancer can safely avoid biopsies after receiving negative MRI results…

Unravelling Genetic Insights into Steatotic Liver Disease Progression

Recent research highlights the discovery of 17 novel loci associated with liver triglycerides and 9 linked to liver inflammation.

Scientists Create First Blood-Generating Heart in the Lab

Scientists create first blood-generating heart organoid, modelling human heart and blood cell development for disease research.

Gabapentin Use Linked to Increased Fracture Risk in Patients with Inflammatory Arthritis

Gabapentinoids, widely prescribed for pain management in inflammatory arthritis (IA), are now linked to a 36% higher risk of fractures.

Orange lungs on yellow background

Respiratory infections cost UK businesses £44bn annually

A new report by the Office of Health Economics (OHE), commissioned by Pfizer, reveals that respiratory infections can be bad for business.